Limits of Colorectal Cancer Screening Today
Colonoscopy is the current standard in Colorectal Cancer (CRC) screening. While accurate, the procedure is invasive, uncomfortable, and expensive, contributing to low compliance among patients. Recently developed fecal-based tests offer the first major advance in CRC screening in decades. However, the expensive test is unable to detect precancerous polyps and some studies show that it too has a low 50% patient compliance, largely due to the unpleasant experience.
Latest Clinical Data
Todos Medical has collected over 1,000 clinical samples in several clinical trials for breast and other cancers at the Wolfson Medical Center (Holon, Israel), Rabin Medical Center (Petach Tikva, Israel), Ichilov Medical center (Tel Aviv, Israel) and in the Ukraine. The latest clinical trial (link to article in publication section) for Todos Medical’s colorectal cancer test included 64 patients and achieved 82% sensitivity and 91% specificy as compared to colonoscopy screening.